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Individual neurodevelopmental disorders are associated with premature mortality. Little is
known about the association between multiple neurodevelopmental markers and premature
mortality at a population level. The ESSENCE (Early Symptomatic Syndromes Eliciting
Neurodevelopmental Clinical Examinations) approach considers multiple neurodevelop-
mental parameters, assessing several markers in parallel that cluster, rather than consider-
ing individual diagnostic categories in isolation.
Objectives
To determine whether childhood neurodevelopmental markers, including reduced intellec-
tual functioning, are associated with all-cause premature mortality.
Methods and procedures
In a general population cohort study (n = 12,150) with longitudinal follow up from childhood
to middle age, Cox proportional hazard models were used to study the associations
between childhood neurodevelopmental markers (Rutter B scale and IQ) and premature all-
cause mortality.
Outcomes and results
The cognitive measures and 21 of the 26 Rutter B items were significantly associated with
premature mortality in bivariate analyses with hazard ratios from 1.24 (95% CI 1.05–1.47) to
2.25 (95% CI 1.78–2.90). In the final adjusted model, neurodevelopmental markers sugges-
tive of several domains including hyperactivity, conduct problems and intellectual
impairment were positively associated with premature mortality and improved prediction of
premature mortality.
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Conclusions
A wide range of neurodevelopmental markers, including childhood IQ, were found to predict
premature mortality in a large general population cohort with longitudinal follow up to 60–65
years of age.
Implications
These findings highlight the importance of a holistic assessment of children with neurodeve-
lopmental markers that addresses a range of neurodevelopmental conditions. Our findings
could open the door to a shift in child public mental health focus, where multiple and/or
cumulative markers of neurodevelopmental conditions alert clinicians to the need for early
intervention. This could lead to a reduction in the risk of broad health outcomes at a popula-
tion level.
Introduction
Several studies have already demonstrated associations between individual neurodevelopmen-
tal disorders and premature mortality: Autism spectrum disorder (ASD) [1], Attention Deficit
Hyperactivity Disorder (ADHD) [2], Conduct Disorder [3, 4], and Intellectual Disability [5]
are all associated with an increased risk of premature death. Despite these disorders being con-
ceptualised as separate entities, comorbidity is in fact “a rule rather than an exception” [6] and
the broad range of symptoms of neurodevelopmental disorders are now known to have a com-
mon genetic underpinning [7]. Although there are some syndrome-specific genetic factors,
they are of much smaller magnitude and unique environmental factors are largely what drives
the manifestation of the underlying neurodevelopmental profile towards a more specific diag-
nostic category [7].
The concept of ESSENCE (Early Symptomatic Syndromes Eliciting Neurodevelopmental
Clinical Examinations) was developed to take account of the clustering of neurodevelopmental
disorders and the overlap in symptoms, even when they fall short of diagnostic thresholds [8].
The ESSENCE approach highlights that it is rare for one neurodevelopmental problem to
occur in isolation, that individual symptoms are markers for the likely presence of additional
neurodevelopmental problems, that markers of neurodevelopmental disorders can cross diag-
nostic boundaries, that clinical presentations can change throughout the life course and that
“sub-clinical” markers across a range of diagnostic areas might be more important for predict-
ing health outcomes than individual diagnoses. We use the term “markers” here because the
term “symptoms” implies reference to a particular disorder whereas it has now been clearly
shown that these markers often index more than one disorder [7]. There is still some debate
about whether symptoms of certain childhood-onset disorders, particularly oppositional and
conduct disorders, should be regarded alongside other Early Symptomatic Syndromes, but
since both neurobiological and environmental risk factors are important in the development
of conduct disorder as for all neurodevelopmental disorders, we regard it as logical to include
markers such as aggression, rule breaking etc. In addition, common childhood symptoms such
as anxiety and depression are extremely common in neurodevelopmental conditions so may
be useful markers for these disorders [9]. Since the publication of the seminal ESSENCE paper
in 2010, robust evidence has begun to accrue that, in population-based longitudinal research,
childhood neurodevelopmental problems are best considered together [10, 11]. It has also
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become clear that children with “behaviour problems” are, in fact, likely to have neurodevelop-
mental problems underpinning these [12].
All neurodevelopmental disorders are associated with a wide range of physical and mental
health problems across the lifespan. For example, nearly all major chronic medical conditions
are significantly more common among adults with a health record of ASD compared to controls
[13] and there are higher rates of long term medical conditions among both children and adults
with ASD compared with the general population [14, 15]. Deceased adults with ASD were
found to have had higher rates of most health problems compared with deceased community
controls [16]. People with intellectual disabilities also have more health problems than other
people [17]. Several prospective longitudinal studies have shown that childhood ADHD is asso-
ciated with impaired general physical and mental health in adulthood [18–20] and ADHD
symptoms persisting into early adulthood are associated with multi-morbidity [21]. Recent
research has shown that tic disorders are associated with increased cardiovascular risk [22].
The risk of poor health outcomes, including premature mortality, is even greater if a child
has more than one neurodevelopmental disorder. In a Swedish population-based cohort of
27,122 participants with ASD and 2,672,185 controls, ASD was associated with an increased
risk of all-cause premature mortality and with most specific causes of premature mortality,
particularly among those with co-existing intellectual disabilities [1]. In a Danish population
cohort study, ASD plus one or more comorbid neurological, behavioural or mental disorders
was associated with a higher risk of premature mortality [23]. In a Danish national register
study of 1,922,248 individuals, including 32,061 with ADHD, ADHD was associated with
increased mortality, with the mortality rate ratio more than doubling in the presence of
comorbid behavioural disorders [2].
Until recently, the implications of the co-occurrence of more than one disorder has not
been addressed in the scientific literature. It was only in the most recent edition of the Diag-
nostic Statistical Manual of Mental Disorders, 5th edition (DSM-V) published in 2013 that the
simultaneous diagnosis of ADHD and autism was formally recognised as possible (previously
ASD was an exclusion criterion for the diagnosis of ADHD). This failure to take clustering of
neurodevelopmental disorders into account has often led to the exclusion from studies of peo-
ple with more than one diagnosis, yet clustering is extremely common: e.g. 95% of people with
ASD have a co-existing disorder and more than 50% have more than four co-existing disorders
[24]. Focussing on isolated disorders may well have led to an underestimation of the disease
burden, and burden of premature mortality, associated with neurodevelopmental conditions
across the lifespan. The recent findings that the full range of neurodevelopmental symptoms
contribute to the common neurodevelopmental genetic factor [7] could have important impli-
cations for public health policy. The traditional clinical focus on those children who meet diag-
nostic criteria for a specific diagnosis may have led to missed opportunities for prevention in
children who have the neurodevelopmental genetic profile yet are “sub-syndromal” for any
particular disorder.
We therefore aim to address the question: Can a broad range of child neurodevelopmental
markers predict premature mortality?
Despite rapidly accruing evidence that a multi-symptom approach to childhood neurodeve-
lopment should underpin population research, no studies have thus far taken such an approach
to examine premature mortality. Traditional registry studies are unable to address this because
registers are kept according to diagnostic categories, which historically have been exclusionary.
Participants in the newer large cohort studies, designed with this holistic approach in mind (e.g.
[25, 26]), are not yet old enough to robustly examine premature mortality. Older UK cohorts
include measures that capture the wide range of emotional and behavioural neurodevelopmen-
tal markers. Although these scales were traditionally used to give global scores for
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psychopathology or to indicate individual likely diagnoses, the individual items are available
and relevant, giving us a unique opportunity to examine this important question.
Materials and methods
Ethical considerations
The use of an anonymised subset of cohort data was approved by the Children of the 1950s
Study Steering Group (project manager contact details https://www.abdn.ac.uk/iahs/research/
public-health-nutrition/profiles/h.clark). Permission to link to health data was granted by the
Public Benefit and Privacy Panel for Health and Social Care (PBPP) (Application 1617–0225/
Warrilow). Data was analysed within the Grampian Data Safe Haven.
Participants
Participants were from the Aberdeen Children of the 1950s (ACoNF) study. Detailed descrip-
tions of the cohort have been previously published [27, 28]. In brief, ACoNF is a general popu-
lation cohort of children attending primary schools in Aberdeen in the 1960s, including
specialist schools for children with learning disabilities. In March 1964, when participants
were aged between eight and 14 years old, routinely conducted cognitive test scores were
recorded as well as measures of reading ability and the Rutter B Scale, a teacher-reported mea-
sure of child neurodevelopmental markers. In 1999, the cohort, then aged between 43 and 49
years old, was traced via the NHS Central Registry to ascertain vital status and residency. Par-
ticipants were flagged at the NHS Central Register for the ACoNF study to receive notification
of future deaths and emigration. Surviving participants resident in the UK were followed up
via a postal questionnaire in 2001–2003. In this study, participants comprised those who were
traced and flagged for follow-up who also had complete childhood data.
Child neurodevelopmental markers
The Rutter B scale is a 26-item questionnaire, completed for each pupil by the teacher that
assesses a wide range of emotional and behavioural symptoms which commonly occur in sev-
eral of the neurodevelopmental disorders, and which henceforth will be referred to as neurode-
velopmental markers. Each question represents an individual neurodevelopmental marker
and includes those markers typical of children with specific disorders: tic disorder (e.g. “has
twitches, mannerisms or tics”); autism (e.g. “solitary”, “fussy”) and ADHD (e.g. “fidgety”,
“poor concentration”)–although children with autism are often hyperactive and children with
ADHD often have tics etc. The full wording of the scale items is listed in S1 Appendix along-
side the shortened form used throughout the text. The questionnaire has been widely utilised
within population research and has demonstrated good psychometric properties [29]. Re-test
reliability was 0.89 for ratings by the same teacher two months apart and inter-rater reliability
was 0.79 for ratings by separate teachers (last term in infant school versus first term in junior
school) [30]. Validity has been assessed by comparison of children who were referred to psy-
chiatric services to those who were not, comparison with psychiatric interview results and by
comparison with other instruments e.g. the Child Behaviour Checklist [29, 30].
The 26 questions have three possible answers: “does not apply”, “applies somewhat” and
“definitely applies”). We collapsed these to “applies” (1) or “not” (0).
Cognitive measures
In the 1960s, children in Scotland routinely sat intelligence quotient (IQ) tests within six
months of their seventh, ninth and eleventh birthdays. At age eleven years, the Moray House
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Verbal Reasoning Tests 1 and 2 were carried out. The mean of these was used as our measure
of IQ. If only one test result was available this was used. If there was no age eleven test score
available, the score from the test at age seven, the Moray House Picture Intelligence Test (No.
1 or 2), was used. If at age seven years children were thought not able to complete the standard
test then an alternative IQ measure was used and if unable to complete any IQ test, as a result
of low cognitive ability, a score of 50 was recorded. To account for any differences in scaling of
these age-standardised measures, IQ was further standardised as a z-score and the inverse z-
score used within the statistical modelling to aid interpretation.
Reading ability was assessed in December 1962 using the National Foundation for Educa-
tional Research (NFER) Sentence Reading Test 1 (for children aged between seven and nine
years) or the NFER Reading Test N.S.6 (for children aged ten or 11 years old). The reading
quotient (RQ) score was transformed into a z-score and the inverse used in the statistical
modelling.
Vital status
Vital status was ascertained from two sources: the UK NHS Central Register and the NHS
Scotland Information Services Division. Information from the UK NHS Central Register was
obtained as part of the ACoNF study data extraction (to June 2014) which includes all those
deaths in the decades prior to the study participants being retraced/recontacted as well as set-
ting up a system to record all deaths occurring thereafter. Information on deaths in Scotland
to December 2015 was provided by the NHS Scotland Information Services Division eData
Research and Innovation Service (eDRIS).
Permission was obtained from the Public Benefit and Privacy Panel for Health and Social
Care (PBPP). To maintain confidentiality, dates of birth and death were provided as month
and year only.
Statistical analyses
Preliminary analyses employed Chi-square tests to examine the association of vital status with
the presence or absence of each of the Rutter items and t-tests for the association with IQ and
Reading Quotient.
Cox proportional hazards regression was used for the main analyses. Age at death or age at
censor date was calculated in months. Censorship occurred at i) date of emigration from the
UK, ii) June 2014 for participants traced and flagged by the NHS Central Register without a
Scottish health record, or iii) December 2015 if participants were matched to a Scottish Health
record at eDRIS.
Separate survival analysis models were carried out for each individual Rutter scale item,
and for Reading Quotient and IQ. A selected multivariable model was derived using backward
elimination from a model containing all Rutter items, RQ and IQ. Age was not associated with
Rutter B items and gender only slightly (see S1 Table) so age and gender were not included in
the model. Of the Rutter B items only one variable (attention) showed a significant interaction
with gender (p = 0.014). All statistical analyses were carried out using STATA v13 within the
Grampian Data Safe Haven.
Results
Of the original 12,150 ACoNF study participants, 909 (7.5%) were excluded from the analyses:
89 because they were not able to be traced in 1999 and 820 because they had missing data on
one or more childhood measures. The final study population therefore comprised 11,241 par-
ticipants of whom 5,844 were male and 5,397 were female. Of the 11,241 participants, 1,167
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(10.4%) were known to have died prematurely by the end of December 2015–63.7% of these
deaths were in males and 36.3% in females. Table 1 shows the frequency of responses to the 26
individual Rutter B behaviours. A wide range of neurodevelopmental markers (18 out of the
26 Rutter B items) were more common in the group who experienced premature mortality.
The mean Intelligence Quotient (IQ) and Reading Quotient (RQ) scores are presented in
Table 2 and are significantly lower in those with premature mortality.
The hazard ratios derived from the univariate Cox proportional hazard analyses are shown
in Fig 1. There was a significant positive association with premature mortality for 21 of the 26
individual Rutter B behaviour items with hazard ratios ranging from 1.24 (CI: 1.05, 1.47) to
2.28 (CI: 1.78, 2.90). Cognitive measures also had a significant association in univariate
Table 1. Frequency of neurodevelopmental markers reported on Rutter B scale by vital status.
Cohort (n = 11,241) Died (n = 1,167) Alive (n = 10,074) P value (χ2, 1df)
n % n % n %
restless 1,899 16.89 254 21.77 1,645 16.33 <0.001
truants 208 1.85 46 3.94 162 1.61 <0.001
fidgety 2,546 22.65 342 29.31 2,204 21.88 <0.001
destroys 362 3.22 69 5.91 293 2.91 <0.001
fights 1,240 11.03 184 15.77 1,056 10.48 <0.001
not liked 1,148 10.21 155 13.28 993 9.86 <0.001
worries 1,946 17.31 204 17.48 1,742 17.29 0.926
solitary 1,419 12.62 161 13.80 1,258 12.49 0.203
irritable 928 8.26 143 12.25 785 7.79 <0.001
unhappy 902 8.02 112 9.60 790 7.84 0.029
tics 417 3.71 54 4.63 363 3.60 0.141
sucks fingers 623 5.54 70 6.00 553 5.49 0.323
bites nails 2,227 19.80 272 23.31 1,955 19.41 0.001
school absences 613 5.45 98 8.40 515 5.11 <0.001
disobedient 1,266 11.26 203 17.40 1,063 10.55 <0.001
attention 3,380 30.07 465 39.85 2,915 28.94 <0.001
afraid of new things 1,686 15.00 186 15.94 1,500 14.89 0.462
fussy 661 5.88 58 4.97 603 5.99 0.355
lies 809 7.20 147 12.60 662 6.57 <0.001
steals 233 2.07 52 4.46 181 1.80 <0.001
wets or soils 153 1.36 14 1.20 139 1.38 0.821
aches and pains 394 3.51 58 4.97 336 3.34 0.001
tears/school refusal 61 0.54 4 0.34 57 0.57 0.674
stutters 237 2.12 34 2.91 203 2.02 0.035
other speech problem 464 4.13 72 6.17 392 3.89 <0.001
bullies 558 4.96 84 7.20 474 4.71 <0.001
n: number; χ2: Pearson Chi-square test; df: degrees of freedom.
https://doi.org/10.1371/journal.pone.0255649.t001
Table 2. Mean cognitive and behavioural scores.
Overall Mean (SD) Died n (%) Alive n (%) P (t test)
IQ 104.00 (13.84) 100.24 (14.11) 104.43 (13.74) p<0.001
RQ 99.02 (15.08) 95.34 (15.74) 99.45 (14.94) p<0.001
IQ: intelligence quotient, RQ: reading quotient, SD: standard deviation, n: number.
https://doi.org/10.1371/journal.pone.0255649.t002
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analyses–for a one standard deviation decrease in IQ there was a 29% greater risk of death, and
for RQ a 16% greater risk of death per standard deviation decrease (IQ (inverse standardised)
HR: 1.29, 95% CI: 1.22, 1.36, p<0.001; RQ (inverse standardised) HR: 1.16, 1.10,1.23, p<0.001).
Adjusting for gender made only very small differences to hazard ratios–see S1 Table.
The individual Rutter B behaviours were entered simultaneously together with IQ and RQ
into an adjusted survival analysis model derived by backwards elimination. The results are
Fig 1. Mortality risk associated with each of the Rutter B items (n = 11,241).
https://doi.org/10.1371/journal.pone.0255649.g001
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displayed in Fig 2. In this adjusted model, gender, IQ and RQ were retained along with seven
Rutter B behaviours. Six of the Rutter B behaviours showed a significant independent positive
association with premature mortality (lies, other speech problem, destroys, aches and pains,
fights, fidgety), whilst not being liked changed direction compared with the univariate analysis.
Of the Rutter B behaviours that predicted a greater risk of death, hazard ratios ranged from
1.21 to 1.50. The magnitude of the association between IQ and premature mortality was
increased within this model compared with the univariate analysis. Lower IQ remained a sig-
nificant predictor of premature mortality, with a one standard deviation decrease in IQ associ-
ated with a 43% greater risk of death (HR: 1.43, 95% CI: 1.29,1.59, p<0.001). The effect of RQ
also changed direction from the univariate analysis when entered into this model (HR: 0.81
95% CI: 0.73,0.90, p<0.001). This was as a result of adjusting for IQ which it is highly corre-
lated with RQ, as the HR was also less than one when RQ and IQ were entered into a model




Our findings demonstrated an association between a wide range of neurodevelopmental mark-
ers, including reduced intellectual functioning, and greater risk of all-cause premature mortal-
ity. The hazard ratios of between 1.24 and 2.28 are of similar magnitude to results from other
studies of childhood behaviour and premature mortality e.g. Maughan et al report hazard
ratios of 1.17 in men and 1.16 in women [3]. To highlight the significance of these results they
can be compared to studies of smoking and all-cause mortality (HR 1.3–2.7) [31, 32]. The
most commonly reported markers were attention problems (30.1%), fidgetiness (22.7%) (both
Fig 2. Selected model from analysis of Rutter B items and cognitive measures (n = 11,241).
https://doi.org/10.1371/journal.pone.0255649.g002
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core symptoms of ADHD diagnosis) and nail biting (19.8%) which is associated with a range
of emotional and behavioural difficulties [33]. In the adjusted model six individual neurodeve-
lopmental markers (lies, speech problems, destroys, fights, aches and pains, fidgety) were posi-
tively associated with premature mortality. These varied markers index several problem
domains, each adding significantly to the prediction of premature mortality by between 21%
and 50%. These domains are: problems with hyperactivity (fidgety), speech problems (com-
mon in autism), conduct problems (destroys, fights, lies), and complaining of aches and pains
(considered a proxy marker of anxiety in children). This shows, for the first time, that child-
hood neurodevelopmental markers in any domain are associated with higher risk of premature
mortality. Each standard deviation of lower IQ was associated with a more than 40% greater
risk of premature mortality. This finding is consistent with previous work in this cohort and in
other studies (Calvin et al, 2011), but our study is novel in demonstrating that individual neu-
rodevelopmental markers predict premature mortality independently of the known associa-
tion between premature mortality and IQ.
It is difficult to account for the result that “not being liked” reduced the risk of premature
death in the adjusted model, especially as poor peer relations and conduct problems (which
greatly increase premature mortality) often go together [34]. This finding needs to be corrobo-
rated and investigated further in other studies.
When controlling for IQ, higher Reading Quotient was associated with a greater risk of pre-
mature mortality. A discrepancy between advanced reading ability and poor comprehension
are features of “hyperlexia” which is strongly associated with autism [35]. This finding would
need replication and further investigation.
There is already a significant body of research demonstrating premature mortality associ-
ated with individual neurodevelopmental diagnoses [1–3, 5] but many children in the general
population are likely to have one or two of these neurodevelopmental markers and most will
not attract a neurodevelopmental diagnosis. This should alert us to the importance of symp-
tom load in child neurodevelopment. In other fields, such as cardiovascular science, risk scores
that calculate global risk across a range of health parameters (e.g. blood pressure, weight and
serum lipid profile) have proven invaluable in identifying people most at need of early inter-
vention to prevent the onset of disease [36]. Our findings could open the door to new consid-
eration of child mental public health with a focus on risk indicators considered individually
and cumulatively with the aim of reducing the risk of broad health outcomes at a population
level. At a clinical level, these findings stress the importance of the ESSENCE approach, i.e.
holistic assessment and treatment of children presenting with developmental difficulties in
order to improve health across the lifespan.
Strengths and weaknesses
A major strength of this study is the examination of the data from an ESSENCE perspective
utilising individual Rutter B behaviours rather than the traditional method of simply calculat-
ing a total Rutter problem score or using single diagnostic categories. The study had a large
sample size (n = 11,241) with 92.5% of the cohort available for complete case analysis. There
has been a sufficiently long follow-up period of fifty years. The study includes those across a
spectrum of cognitive abilities including those with intellectual disabilities attending specialist
schools in addition to those in mainstream primary schools. Linkage to national records is a
particular strength as the study was able to include those that may traditionally be lost to follow
up (e.g. those with lower IQ) ensuring the study population was representative of the general
population of the time. We only used the teacher reported scale and, while parent and teacher
report can differ slightly in the way they describe a child’s problems, the Rutter B (teacher)
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scale has good psychometric properties even compared to the parent version [29]. It possible
that including a parent-report version (which asks slightly different questions) might have
added further insights about risks for premature mortality but the numbers with parent-report
questionnaires was too low for these kinds of analyses. It would also have been interesting to
examine the extent to which these teacher-reported neurodevelopmental markers resulted in
referrals for clinical assessments and this could be a focus of future research using data linkage.
Implications
This study highlights the importance of considering childhood neurodevelopmental markers,
including IQ, across all domains, including symptoms that are “sub-threshold” for individual
diagnoses, given the contribution of these to premature mortality. ESSENCE is relatively
recently described, and our study provides direct evidence to support this approach as well as
the need for consideration of a broad range of neurodevelopmental markers in assessment and
treatment of children with neurodevelopmental presentations.
Future research
Further investigation is needed to better understand the mechanisms linking childhood neuro-
developmental markers with adult health outcomes that are responsible for excess premature
deaths. Important next steps will be to investigate how these neurodevelopmental markers
cluster, how they change in their expression and impact across childhood, through adolescence
and into adulthood and how they relate–together and in clusters–to disease processes. A better
understanding of the underlying causes of premature mortality may enable the development
of preventative approaches that are relevant to children and adults with ESSENCE symptoms.
Conclusion
This study of 1,167 premature deaths in a general population cohort of 11,241 participants has
demonstrated that neurodevelopmental markers relating to the major domains of child psy-
chopathology, including reduced intellectual functioning in childhood, substantially increase
the risk of premature mortality.
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